课题基金 / 基金详情

Modulation of Macrophages Activity by Human T-lymphocyte-derived Microparticles Contributes to their Antiangiogenic Effects in Ischemic Retinopathy

Modulation of Macrophages Activity by Human T-lymphocyte-derived Microparticles Contributes to their Antiangiogenic Effects in Ischemic Retinopathy
人 T 淋巴细胞衍生微粒对巨噬细胞活性的调节有助于其在缺血性视网膜病变中的抗血管生成作用
批准号：
342256
负责人：
Hardy Pierre
金额：
$27.85万
依托单位：
Centre hospitalier universitaire Sainte-Justine (Montral, Qubec)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-03-01 至 2020-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=342256&lang=en
关键词：
Antiangiogenesis Extracellular Microvesicles Lymphocytic Microparticles Macrophages Oxygen-Induced Retinopathy Retinal Neovascularization Retinopaghy Of Prematurity Treatment Of Disease Vascular Biology

项目摘要

项目成果

Hardy Pierre的其他基金

相似基金

相关文献

中文摘要
翻译
视网膜是排列在眼睛后部的一层光敏细胞，帮助我们看东西。如果婴儿出生得太早，视网膜上的血管还没有发育完全。早产儿视网膜病变（Retinopathy of prematurity， ROP）是指胎儿的生长不正常
英文摘要
The retina is a light-sensitive layer of cells lining the back of the eye that help us to see. When babies are born too early, the blood vessels on the retina are not fully developed. Retinopathy of prematurity (ROP) is the name for the improper growth of
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of the antineoplastic effect of miRNA-181a and development a novel pharmaceutical approaches for treating advanced retinoblastoma
海外基金